During the past decade, CH Laon conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Laon" #1 sponsor was "Centre Hospitalier Universitaire, Amiens" with 3 trials, followed by "ARCAGY/ GINECO GROUP" with 1 trials sponsored, "Central Hospital, Nancy, France" with 1 trials sponsored, "Centre Hospitalier de Charleville-Mézières" with 1 trials sponsored and "Groupe Hospitalier de la Rochelle Ré Aunis" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Laon" #1 collaborator was "Centre de traitement des données du Cancéropôle Nord-Ouest, Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator, "Coloplast A/S" with 1 trials as a collaborator, "Institut National de la Santé et de la Recherche Médical (INSERM) 1086 (Pr Guy LAUNOY) Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator, "Institut Pasteur" with 1 trials as a collaborator and "Pierre Fabre Laboratories" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "CH Laon" are "Breast Cancer" (1 trials), "Cancer" (1 trials), "Carcinoma" (1 trials), "Clinical Research" (1 trials) and "Hemorrhagic Fever With Renal Syndrome" (1 trials). Many other conditions were trialed in "CH Laon" in a lesser frequency.

Most popular intervention types in "CH Laon" are "Other" (3 trials), "Drug" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "meconium" (2 trials), "5-Fluoro-uracil" (1 trials), "Anastrozole" (1 trials), "Folinic Acid" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH Laon" are 6 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CH Laon". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in CH Laon, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CH Laon, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".